Directional Coronary Atherectomy KFSH & RC Experience Layth A. Mimish, J. Buraiki, M. E. Fawzy, B. Dunn, M. Bakhshi, B. Dajani.

Slides:



Advertisements
Similar presentations
Clinical Trial Results. org ABSORB Presented at the American College of Cardiology Annual Scientific Session March, 2007 Presented by Dr. Patrick W. Serruys.
Advertisements

Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Optimal Management of ACS Invasive vs Conservative Strategy
AVE Micro Stent KFSH & RC Experience with 6 months Angiographic Follow Up Layth A. Mimish, M. Bakhshi, F. Al-Nozha, A. Kinsara, O. Amoudi, J. Buraiki,
Layth Ahmad Mimish Consultant Cardiologist The Cardiovascular Consultants Group Jeddah, KSA.
Complications of HSRA Layth A. Mimish Consultant Cardiologist Cardiovascular Consultants Group Jeddah, Saudi Arabia.
Plaque Debulking Prior to Stenting Dr. Layth A. Mimish The Cardiovascular Consultants Group Jeddah, Saudi Arabia.
30 th Annual Meeting of The Egyptian Society of Cardiology.
Rotablation or Balloon Immediate and 6 month results of a trial in patients with chronic total coronary occlusion Layth A. Mimish, M. Bakhshi, J. Buraiki,
Left Main Coronary Artery Dissection Complicating Diagnostic Coronary Angiography Layth A. Mimish MBChB, FRCPC, FACC Medical Director The Cardiovascular.
29th ANNUAL SCIENTIFIC SESSIONS – SCA&I
Call for CASES Staged PCI in a patient with multivessel coronary disease disqualified from CABG. Pawel Buszman, MD, FESC, FSCAI Marcin Debinski, MD Krzysztof.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Chaim Lotan MD, Yaron Almagor MD, Karel Kuiper MD, M.J. Suttorp MD, William Wijns MD The SICTO Study CYPHER TM Sirolimus-eluting stent in Chronic Total.
C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides
As presented by Patrick W. Serruys, MD, PhD, FACC Principal Investigator Thoraxcentre - Erasmus University Rotterdam, The Netherlands PISCES Paclitaxel.
SCAAR UCR SWEDEN 2007 Stefan James, Jörg Carlsson, Johan Lindbäck, Tage Nilsson, Ulf Stenestrand, Lars Wallentin and Bo Lagerqvist for the SCAAR study.
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
Coronary Artery Disease in Diabetic Patients, Different from Non-diabetics?
Peripheral Arterial Disease Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
Richard Melsheimer Director, Medical Affairs Europe Centocor Eli Lilly and Company Coordinated Use of ReoPro and Drug Eluting Stents: Rationale and Evidence.
As presented by Keith D Dawkins MD FRCP FACC Southampton University Hospital United Kingdom EuroSTAR The European Cobalt Stent with Antiproliferative for.
Tetra Randomized European Direct Stenting Study (TRENDS)
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
AICT 2010-Athens Interventional Cardiovascular Therapeutics XI 8-9 OCTOBER 2010 Divani Caravel Hotel, Αthens EARLY CLINICAL OUTCOMES AFTER PROMUS ELEMENT.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.
David Hildick-Smith Sussex Cardiac Centre. Background to ARTS Previous POBA studies Meta-analysis 3300 patients 1660 CABG, 1710 PTCA Deaths 79 PCI vs.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
Is the Decision-Making after Failure of CTO Angioplasty Same? Infarct Related CTO or Non- Infarct Related CTO (Continue the Procedure in Other Vessel or.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.
Endeavor 4: A Randomized Comparison of a Zotarolimus- Eluting Stent and a Paclitaxel- Eluting Stent in Patients with Coronary Artery Disease Martin B.
Renal Intervention by the Radial Approach Josef Ludwig, Erlangen Angiosoft.NET.
Hybrid Off-Pump Revascularization; Early & Midterm Results 서울대학교병원 흉부외과 황 호영, 조 광리, 김 기봉.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Treatment of Protected and Unprotected.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Revascularization of the Heart
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
Latvian Centre of Cardiology real-life registry
Coronary stent immobilisation with rapid ventricular pacing technique via coronary guidewire in non-ST elevation myocardial infarction Dr Zaid Iskandar.
Interesting Case Presentation
Layth A. Mimish, M. Bakhshi, J. Buraiki,
Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,
Patient clinical characteristics (n=123)
The Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel
Meruzhan Saghatelyan, MD, Interventional cardiologist
Procedural factors associated with PCI-related ischemic stroke
David J. Cohen, M.D., M.Sc. Director of Cardiovascular Research
TAXUS IV Trial Slow-rate release polymer-based paclitaxel-eluting stent compared with bare stent in patients with single de novo coronary lesions Presented.
BVS Expand: First Results of Wide Clinical Applications
Subintimal Tracking and Reentry for CTO STAR Method
Fractional Flow Reserve Workshop
Stenting of Coronary Arteries in Non Stress/Benestent Disease
TAXUS II and IV: two-year follow-up
American College of Cardiology Presented by Dr. Stephan Windecker
EXCITE ISR Trial design: Participants with femoropopliteal in-stent restenosis were randomized to excimer laser atherectomy + adjunctive angioplasty (n.
Giuseppe Biondi Zoccai, MD
Presented at ACC 2003 Late Breaking Clinical Trials
SIRIUS: A U.S. Multicenter, Randomized, Double-Blind Study of the SIRolImUS-Eluting Stent in De Novo Native Coronary Lesions Presented at TCT 2002.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Presented at TCT 2006.
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
The American College of Cardiology Presented by Dr. A. Abazid
The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization  Lorenzo Azzalini,
Presentation transcript:

Directional Coronary Atherectomy KFSH & RC Experience Layth A. Mimish, J. Buraiki, M. E. Fawzy, B. Dunn, M. Bakhshi, B. Dajani

DCA u 1st case performed in KFSH in December Total 149 cases u cases u cases u cases u cases u 1996/97 3 cases

Demographic & Clinical Data u Mean Age years u Males/Females 136/13 u CCS class II-IV 140/149 u History of MI 83(67 QMI) u Restenotic lesions 36

DCA u LAD 121 u Circumflex 9 u Intermediate 1 u RCA 18 u 33 procedures were done to shave dissection flaps ( 24 are salvage procedures)

DCA u Mean artery size mm u Atherocath sizes 5 F 19 5 F 19 6F 75 6F 75 7F 55 7F 55

Additional procedures u PTCA 92 u Thrombolysis 4 u Stenting 2 u PCPBS 3

Success & Major Comlications u Successful in 142/149 cases (95.3%) u In 2 patients Atherocath could not be advanced despite predilatation u In 5 patients emergency CABG had to be done, with one mortality post CABG u No QMI

Minor Complications u Acute occlusion 4 u Ventricular Fibrillation 1 u Transient Arrhythmias 2 u Long dissection 2 u Haematoma 2 u Non QMI 13 u Coronary Embolus 5

6 Months angiographic follow up u Cathetarization performed on 139 of the 142 patients who had successful atherectomy. u Restenoses in 46/139 patients (33%)

Conclusion u DCA is an effective tool for coronary revascularization which carries a high success rate and in large vessels an acceptable restenosis rate u Technically it is more demanding than simple GOBA

Debulking Revisited Layth A. Mimish Consultant Cardiologist The Cardiovascular Consultant Group Jeddah, Saudi Arabia Jeddah, Saudi Arabia

Percutaneous Revascularization u Initial gain with device u Mechanism of initial gain u Lesion specific device u IVUS u Initial loss (recoil) u Injury and cellular proliferation

Percutaneous Revascularization u Initial gain with device u Mechanism of initial gain u Lesion specific device u IVUS u Initial loss (recoil) u Injury and cellular proliferation